India’s vaccination policy is under severe public scrutiny. And that may already be producing better approaches – the Centre booked 30 crore doses of Biological E’s under-trial vaccine with a Rs 1,500 crore advance. Biological...
from Times of India Opinion https://ift.tt/3z36eom
No comments:
Post a Comment